Works by Barr, Paul M.

Results: 61

Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e260, doi. 10.1016/j.clml.2023.05.010
By:
- Thapa, Kriti;
- Strawderman, Myla;
- Reagan, Patrick M.;
- Barr, Paul M.;
- Zent, Clive S.;
- Friedberg, Jonathan W.;
- Faugh, Tina;
- Casulo, Carla
Publication type:
Article
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 515, doi. 10.1016/j.clml.2023.03.010
By:
- Shadman, Mazyar;
- Manzoor, Beenish S.;
- Sail, Kavita;
- Tuncer, Hande H.;
- Allan, John N.;
- Ujjani, Chaitra;
- Emechebe, Nnadozie;
- Kamalakar, Rajesh;
- Coombs, Catherine C.;
- Leslie, Lori;
- Barr, Paul M.;
- Brown, Jennifer R.;
- Eyre, Toby A.;
- Rampotas, Alexandras;
- Schuh, Anna;
- Lamanna, Nicole;
- Skarbnik, Alan;
- Roeker, Lindsey E.;
- Bannerji, Rajat;
- Eichhorst, Barbara
Publication type:
Article
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
Published in:
2019
By:
- Kipps, Thomas J.;
- Fraser, Graeme;
- Coutre, Steven E.;
- Brown, Jennifer R.;
- Barrientos, Jacqueline C.;
- Barr, Paul M.;
- Byrd, John C.;
- O'Brien, Susan M.;
- Dilhuydy, Marie-Sarah;
- Hillmen, Peter;
- Jaeger, Ulrich;
- Moreno, Carol;
- Cramer, Paula;
- Stilgenbauer, Stephan;
- Chanan-Khan, Asher A.;
- Mahler, Michelle;
- Salman, Mariya;
- Eckert, Karl;
- Solman, Isabelle G.;
- Balasubramanian, Sriram
Publication type:
journal article
Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S303, doi. 10.1016/j.clml.2019.07.262
By:
- Zinzani, Pier Luigi;
- Santoro, Armando;
- Gritti, Guiseppe;
- Brice, Pauline;
- Barr, Paul M.;
- Kuruvilla, John;
- Cunningham, David;
- Kline, Justin;
- Johnson, Nathalie A.;
- Mehta-Shah, Neha A.;
- Manley, Thomas;
- Francis, Stephen;
- Sharma, Manish;
- Moskowitz, Alison J.
Publication type:
Article
Five-Year Follow-Up After Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S274, doi. 10.1016/j.clml.2019.07.205
By:
- Burger, Jan;
- Tedeschi, Alessandra;
- Barr, Paul M.;
- Robak, Tadeusz;
- Owen, Carolyn;
- Ghia, Paolo;
- Bairey, Osnat;
- Hillmen, Peter;
- Coutre, Steven E.;
- Devereux, Stephen;
- Grosicki, Sebastian;
- McCarthy, Helen;
- Li, Jianyong;
- Simpson, David;
- Offner, Fritz;
- Moreno, Carol;
- Dai, Sandra;
- Lal, Indu;
- Dean, James P.;
- Kipps, Thomas J.
Publication type:
Article
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience.
Published in:
2019
By:
- Williams, AnnaLynn M.;
- Baran, Andrea M.;
- Casulo, Carla;
- Reagan, Patrick;
- Friedberg, Jonathan W.;
- Helber, Margaret;
- Moore, Jeremiah;
- Baloga, Elizabeth;
- Zent, Clive S.;
- Barr, Paul M.
Publication type:
journal article
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma.
Published in:
2018
By:
- David, Rachel J.;
- Baran, Andrea;
- Loh, Kah Poh;
- Casulo, Carla;
- Barr, Paul M.;
- Friedberg, Jonathan W.;
- Reagan, Patrick M.
Publication type:
journal article
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma.
Published in:
2018
By:
- O'Brien, Susan;
- Hillmen, Peter;
- Coutre, Steven;
- Barr, Paul M.;
- Fraser, Graeme;
- Tedeschi, Alessandra;
- Burger, Jan A.;
- Dilhuydy, Marie-Sarah;
- Hess, Georg;
- Moreno, Carol;
- Cramer, Paula;
- Liu, Emily;
- Chang, Stephen;
- Vermeulen, Jessica;
- Styles, Lori;
- Howes, Angela;
- James, Danelle F.;
- Patel, Kalpesh;
- Graef, Thorsten;
- Valentino, Rudolph
Publication type:
journal article
Tumor Debulking and Reduction in Risk of Tumor Lysis Syndrome with Single-Agent Ibrutinib.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S304, doi. 10.1016/j.clml.2017.07.100
By:
- Kipps, Thomas J.;
- Wierda, William G.;
- Byrd, John C.;
- O’Brien, Susan;
- Coutre, Steven;
- Barr, Paul M.;
- Furman, Richard R.;
- Burger, Jan A.;
- Stevens, Don;
- Sharman, Jeff;
- Ghia, Paolo;
- Flinn, Ian;
- Zhou, Cathy;
- Ninomoto, Joi;
- James, Danelle F.;
- Tam, Constantine
Publication type:
Article
Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.
Published in:
2017
By:
- Hunter, Bradley D.;
- Herr, Megan;
- Meacham, Philip J.;
- Barlaskar, Ferdous;
- Evans, Andrew G.;
- Burack, W. Richard;
- Liesveld, Jane L.;
- Becker, Michael W.;
- Milner, Laurie A.;
- Constine, Louis S.;
- Dhakal, Sughosh;
- Barr, Paul M.;
- Friedberg, Jonathan W.;
- Casulo, Carla
Publication type:
journal article
Survival of Secondary Central Nervous System Lymphoma Patients in the Rituximab Era.
Published in:
2016
By:
- Herr, Megan M.;
- Mohile, Nimish A.;
- Barr, Paul M.;
- van Wijngaarden, Edwin;
- Brown, Edward B.;
- Rich, David Q.
Publication type:
journal article
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma.
Published in:
2016
By:
- Reagan, Patrick M.;
- Baran, Andrea;
- Kelly, Jennifer L.;
- Barr, Paul M.;
- Casulo, Carla;
- Chengazi, Vaseem U.;
- Friedberg, Jonathan W.
Publication type:
journal article
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study.
Published in:
Cancer Medicine, 2020, v. 9, n. 22, p. 8468, doi. 10.1002/cam4.3470
By:
- Cuneo, Antonio;
- Mato, Anthony R.;
- Rigolin, Gian Matteo;
- Piciocchi, Alfonso;
- Gentile, Massimo;
- Laurenti, Luca;
- Allan, John N.;
- Pagel, John M.;
- Brander, Danielle M.;
- Hill, Brian T.;
- Winter, Allison;
- Lamanna, Nicole;
- Tam, Constantine S.;
- Jacobs, Ryan;
- Lansigan, Frederick;
- Barr, Paul M.;
- Shadman, Mazyar;
- Skarbnik, Alan P.;
- Pu, Jeffrey J.;
- Sehgal, Alison R.
Publication type:
Article
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.
Published in:
Cancer Medicine, 2016, v. 5, n. 11, p. 3059, doi. 10.1002/cam4.879
By:
- Reid, Robin M.;
- Baran, Andrea;
- Friedberg, Jonathan W.;
- Phillips, Gordon L.;
- Liesveld, Jane L.;
- Becker, Michael W.;
- Wedow, Lucy;
- Barr, Paul M.;
- Milner, Laurie A.
Publication type:
Article
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
Published in:
Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01520-7
By:
- Vose, Julie M.;
- Fu, Kai;
- Wang, Lu;
- Mansoor, Adnan;
- Stewart, Douglas;
- Cheng, Hongxia;
- Smith, Lynette;
- Yuan, Ji;
- Qureishi, Hina Naushad;
- Link, Brian K.;
- Cessna, Melissa H.;
- Barr, Paul M.;
- Kahl, Brad S.;
- Mckinney, Matthew S.;
- Khan, Nadia;
- Advani, Ranjana H.;
- Martin, Peter;
- Goy, Andre H.;
- Phillips, Tycel J.;
- Mehta, Amitkumar
Publication type:
Article
Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States.
Published in:
British Journal of Haematology, 2019, v. 186, n. 2, p. 255, doi. 10.1111/bjh.15923
By:
- Geer, Marcus;
- Roberts, Emily;
- Shango, Maryann;
- Till, Brian G.;
- Smith, Stephen D.;
- Abbas, Hashim;
- Hill, Brian T.;
- Kaplan, Jason;
- Barr, Paul M.;
- Caimi, Paolo;
- Stephens, Deborah M.;
- Lin, Emily;
- Herrera, Alex F.;
- Rosenbaum, Evan;
- Amengual, Jennifer E.;
- Boonstra, Philip S.;
- Devata, Sumana;
- Wilcox, Ryan A.;
- Kaminski, Mark S.;
- Phillips, Tycel J.
Publication type:
Article
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single‐agent ibrutinib in patients with chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2019, v. 186, n. 1, p. 184, doi. 10.1111/bjh.15791
By:
- Wierda, William G.;
- Byrd, John C.;
- O'Brien, Susan;
- Coutre, Steven;
- Barr, Paul M.;
- Furman, Richard R.;
- Kipps, Thomas J.;
- Burger, Jan A.;
- Stevens, Don A.;
- Sharman, Jeff;
- Ghia, Paolo;
- Flinn, Ian W.;
- Zhou, Cathy;
- Ninomoto, Joi;
- James, Danelle F.;
- Tam, Constantine S.
Publication type:
Article
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.
Published in:
British Journal of Haematology, 2019, v. 186, n. 1, p. 175, doi. 10.1111/bjh.15784
By:
- Burger, Jan A.;
- Cramer, Paula;
- Barr, Paul M.;
- Dilhuydy, Marie‐Sarah;
- Mato, Anthony;
- Byrd, John C.;
- Chang, Stephen;
- Graef, Thorsten;
- Lin, Tony;
- Tedeschi, Alessandra
Publication type:
Article
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor.
Published in:
British Journal of Haematology, 2019, v. 185, n. 5, p. 961, doi. 10.1111/bjh.15666
By:
- Wierda, William G.;
- Byrd, John C.;
- Davids, Matthew S.;
- Furman, Richard R.;
- Cheson, Bruce D.;
- Barr, Paul M.;
- Eradat, Herbert;
- Heffner, Leonard;
- Zhou, Lang;
- Verdugo, Maria;
- Potluri, Jalaja;
- Choi, Michael
Publication type:
Article
Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.
Published in:
British Journal of Haematology, 2017, v. 178, n. 2, p. 286, doi. 10.1111/bjh.14660
By:
- Jones, Jeffrey A.;
- Hillmen, Peter;
- Coutre, Steven;
- Tam, Constantine;
- Furman, Richard R.;
- Barr, Paul M.;
- Schuster, Stephen J.;
- Kipps, Thomas J.;
- Flinn, Ian W.;
- Jaeger, Ulrich;
- Burger, Jan A.;
- Cheng, Mei;
- Ninomoto, Joi;
- James, Danelle F.;
- Byrd, John C.;
- O'Brien, Susan M.
Publication type:
Article
RB but not R- HCVAD is a feasible induction regimen prior to auto- HCT in frontline MCL: results of SWOG Study S1106.
Published in:
British Journal of Haematology, 2017, v. 176, n. 5, p. 759, doi. 10.1111/bjh.14480
By:
- Chen, Robert W.;
- Li, Hongli;
- Bernstein, Steven H.;
- Kahwash, Samir;
- Rimsza, Lisa M.;
- Forman, Stephen J.;
- Constine, Louis;
- Shea, Thomas C.;
- Cashen, Amanda F.;
- Blum, Kristie A.;
- Fenske, Timothy S.;
- Barr, Paul M.;
- Phillips, Tycel;
- Leblanc, Michael;
- Fisher, Richard I.;
- Cheson, Bruce D.;
- Smith, Sonali M.;
- Faham, Malek;
- Wilkins, Jennifer;
- Leonard, John P.
Publication type:
Article
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma.
Published in:
British Journal of Haematology, 2009, v. 147, n. 1, p. 89, doi. 10.1111/j.1365-2141.2009.07836.x
By:
- Barr, Paul M.;
- Pingfu Fu;
- Lazarus, Hillard M.;
- Horvath, Nancy;
- Gerson, Stanton L.;
- Koc, Omer N.;
- Bahlis, Nizar J.;
- Snell, Michael R.;
- Dowlati, Afshin;
- Cooper, Brenda W.
Publication type:
Article
Nursing Experience in Patients Receiving Long-Term Ibrutinib for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Final Analysis Results from Phase 3 RESONATE Study.
Published in:
Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 505
By:
- Settlemire, Jillian;
- Bushart, Jocelyn E.;
- Dai, Sandra;
- Dean, James P.;
- Arthur, David;
- Barr, Paul M.;
- Coutre, Steven
Publication type:
Article
Restoring Quality of Life and Hematologic Function with Ibrutinib in Treatment-Naive Patients with Chronic Lymphocytic Leukemia in the RESONATE-2 Study.
Published in:
Journal of Oncology Navigation & Survivorship, 2016, v. 7, n. 9, p. 58
By:
- Deisinger, Sara;
- Greenberg, Edythe;
- Zhou, Cathy;
- Styles, Lori;
- James, Danelle;
- Burger, Jan A.;
- Barr, Paul M.
Publication type:
Article
Recommendations for Clinical Trial Development in Follicular Lymphoma.
Published in:
2017
By:
- Maddocks, Kami;
- Barr, Paul M.;
- Cheson, Bruce D.;
- Little, Richard F.;
- Baizer, Lawrence;
- Kahl, Brad S.;
- Leonard, John P.;
- Fowler, Nathan;
- Gordon, Leo I.;
- Link, Brian K.;
- Friedberg, Jonathan W.;
- Ansell, Stephen M.
Publication type:
journal article
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271
By:
- Eyre, Toby A.;
- Roeker, Lindsey E.;
- Fox, Christopher P.;
- Gohill, Satyen H.;
- Walewska, Renata;
- Walter, Harriet S.;
- Forconi, Francesco;
- Broom, Angus;
- Arumainathan, Arvind;
- Brander, Danielle M.;
- Allan, John N.;
- Schuster, Stephen J.;
- Hill, Brian T.;
- Lansigan, Frederick;
- Cheson, Bruce D.;
- Lamanna, Nicole;
- Coombs, Catherine C.;
- Barr, Paul M.;
- Skarbnik, Alan P.;
- Shadman, Mazyar
Publication type:
Article
Efficacy of lenalidomide in high‐risk diffuse large B‐cell lymphoma.
Published in:
British Journal of Haematology, 2020, v. 188, n. 4, p. e33, doi. 10.1111/bjh.16302
By:
- Rodgers, Thomas D.;
- Baran, Andrea;
- Reagan, Patrick M.;
- Casulo, Carla;
- Zent, Clive;
- Evans, Andrew;
- Burack, Richard;
- Williams, AnnaLynn M.;
- Friedberg, Jonathan W.;
- Barr, Paul M.
Publication type:
Article
Initial treatment of B‐cell prolymphocytic leukemia with ibrutinib.
Published in:
American Journal of Hematology, 2020, v. 95, n. 5, p. E108, doi. 10.1002/ajh.25733
By:
- Moore, Jeremiah;
- Baran, Andrea M.;
- Meacham, Philip J.;
- Evans, Andrew G.;
- Barr, Paul M.;
- Zent, Clive S.
Publication type:
Article
Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy.
Published in:
American Journal of Hematology, 2020, v. 95, n. 1, p. E16, doi. 10.1002/ajh.25663
By:
- Williams, AnnaLynn M.;
- Baran, Andrea M.;
- Schaffer, Mahlon;
- Bushart, Jocelyn;
- Rich, Lynn;
- Moore, Jeremiah;
- Barr, Paul M.;
- Zent, Clive S.
Publication type:
Article
Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Published in:
American Journal of Hematology, 2019, v. 94, n. 12, p. 1353, doi. 10.1002/ajh.25638
By:
- Munir, Talha;
- Brown, Jennifer R.;
- O'Brien, Susan;
- Barrientos, Jacqueline C.;
- Barr, Paul M.;
- Reddy, Nishitha M.;
- Coutre, Steven;
- Tam, Constantine S.;
- Mulligan, Stephen P.;
- Jaeger, Ulrich;
- Kipps, Thomas J.;
- Moreno, Carol;
- Montillo, Marco;
- Burger, Jan A.;
- Byrd, John C.;
- Hillmen, Peter;
- Dai, Sandra;
- Szoke, Anita;
- Dean, James P.;
- Woyach, Jennifer A.
Publication type:
Article
Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis.
Published in:
American Journal of Hematology, 2019, v. 94, n. 5, p. 554, doi. 10.1002/ajh.25436
By:
- O'Brien, Susan M.;
- Byrd, John C.;
- Hillmen, Peter;
- Coutre, Steven;
- Brown, Jennifer R.;
- Barr, Paul M.;
- Barrientos, Jacqueline C.;
- Devereux, Stephen;
- Robak, Tadeusz;
- Reddy, Nishitha M.;
- Kipps, Thomas J.;
- Tedeschi, Alessandra;
- Cymbalista, Florence;
- Ghia, Paolo;
- Chang, Stephen;
- Ninomoto, Joi;
- James, Danelle F.;
- Burger, Jan A.
Publication type:
Article
Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial.
Published in:
American Journal of Hematology, 2018, v. 93, n. 11, p. 1394, doi. 10.1002/ajh.25261
By:
- Mato, Anthony R.;
- Roeker, Lindsey E.;
- Allan, John N.;
- Pagel, John M.;
- Brander, Danielle M.;
- Hill, Brian T.;
- Cheson, Bruce D.;
- Furman, Richard R.;
- Lamanna, Nicole;
- Tam, Constantine S.;
- Handunnetti, Sasanka;
- Jacobs, Ryan;
- Lansigan, Frederick;
- Bhavsar, Erica;
- Barr, Paul M.;
- Shadman, Mazyar;
- Skarbnik, Alan P.;
- Goy, Andre;
- Beach, Douglas F.;
- Svoboda, Jakub
Publication type:
Article
Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies.
Published in:
American Journal of Hematology, 2018, v. 93, n. 11, p. 1402, doi. 10.1002/ajh.25259
By:
- Robak, Tadeusz;
- Burger, Jan A.;
- Tedeschi, Alessandra;
- Barr, Paul M.;
- Owen, Carolyn;
- Bairey, Osnat;
- Hillmen, Peter;
- Simpson, David;
- Grosicki, Sebastian;
- Devereux, Stephen;
- McCarthy, Helen;
- Coutre, Steven E.;
- Quach, Hang;
- Gaidano, Gianluca;
- Maslyak, Zvenyslava;
- Stevens, Don A.;
- Moreno, Carol;
- Gill, Devinder S.;
- Flinn, Ian W.;
- Gribben, John G.
Publication type:
Article
A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806.
Published in:
American Journal of Hematology, 2018, v. 93, n. 4, p. 486, doi. 10.1002/ajh.25010
By:
- Persky, Daniel O.;
- Li, Hongli;
- Rimsza, Lisa M.;
- Barr, Paul M.;
- Popplewell, Leslie L.;
- Bane, Charles L.;
- Von Gehr, Ann;
- LeBlanc, Michael;
- Fisher, Richard I.;
- Smith, Sonali M.;
- Friedberg, Jonathan W.
Publication type:
Article
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.
Published in:
American Journal of Hematology, 2009, v. 84, n. 8, p. 484, doi. 10.1002/ajh.21449
By:
- Barr, Paul M.;
- Lazarus, Hillard M.;
- Cooper, Brenda W.;
- Schluchter, Mark D.;
- Panneerselvam, Ashok;
- Jacobberger, James W.;
- Hsu, Jack W.;
- Janakiraman, Nalini;
- Simic, Aleksandra;
- Dowlati, Afshin;
- Remick, Scot C.
Publication type:
Article
Non-Hodgkin's Lymphoma in the Elderly.
Published in:
Drugs & Aging, 2010, v. 27, n. 3, p. 211, doi. 10.2165/11531550-000000000-00000
By:
- Caimi, Paolo F.;
- Barr, Paul M.;
- Berger, Nathan A.;
- Lazarus, Hillard M.
Publication type:
Article
Pitfalls of Combining Novel Agents in Lymphoma.
Published in:
2018
By:
- Rodgers, Thomas D.;
- Barr, Paul M.
Publication type:
journal article
COUNTERPOINT: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Published in:
Oncology (08909091), 2018, v. 32, n. 8, p. 404
By:
- Barr, Paul M.
Publication type:
Article
Diffuse Large B-Cell Lymphoma in the Very Elderly: The Case for Refining Our Clinical Trials.
Published in:
Oncology (08909091), 2013, v. 27, n. 2, p. 140
By:
- BARR, PAUL M.
Publication type:
Article
Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Published in:
Leukemia & Lymphoma, 2023, v. 64, n. 9, p. 1579, doi. 10.1080/10428194.2023.2223743
By:
- Wallace, Danielle S.;
- Rowland, Chris;
- Hill, Brian T.;
- Baran, Andrea M.;
- Casulo, Carla;
- Reagan, Patrick M.;
- Winter, Allison;
- Karmali, Reem;
- Winter, Jane N.;
- Gordon, Leo I.;
- Bui, Andrew;
- Sportelli, Peter;
- Miskin, Hari P.;
- Weiss, Michael S.;
- Friedberg, Jonathan W.;
- Ma, Shuo;
- Barr, Paul M.
Publication type:
Article
Phase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma.
Published in:
Leukemia & Lymphoma, 2022, v. 63, n. 7, p. 1728, doi. 10.1080/10428194.2022.2043301
By:
- Barr, Paul M.;
- Smith, Stephen D.;
- Roschewski, Mark J.;
- O'Brien, Susan M.;
- Sharman, Jeff P.;
- Melear, Jason M.;
- Patel, Priti;
- Calvo, Roser;
- Yang, Helen;
- Spurgeon, Stephen E.
Publication type:
Article
Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma.
Published in:
Leukemia & Lymphoma, 2022, v. 63, n. 7, p. 1580, doi. 10.1080/10428194.2022.2038372
By:
- Siddiqi, Tanya;
- Coutre, Steven;
- McKinney, Matthew;
- Barr, Paul M.;
- Rogers, Kerry;
- Mokatrin, Ahmad;
- Valentino, Rudy;
- Szoke, Anita;
- Deshpande, Sanjay;
- Zhu, Angeline;
- Arango-Hisijara, Israel;
- Osei-Bonsu, Kojo;
- Wang, Michael;
- O'Brien, Susan
Publication type:
Article
Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Published in:
2021
By:
- Woyach, Jennifer;
- Tedeschi, Alessandra;
- Munir, Talha;
- Siddiqi, Tanya;
- Hillmen, Peter;
- Byrd, John C.;
- Ghia, Paolo;
- Mulligan, Stephen P.;
- Dai, Sandra;
- Amaya-Chanaga, Carlos I.;
- Dean, James P.;
- O'Brien, Susan M.;
- Barr, Paul M.
Publication type:
Letter
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma.
Published in:
Leukemia & Lymphoma, 2021, v. 62, n. 3, p. 598, doi. 10.1080/10428194.2020.1837796
By:
- Rodgers, Thomas D.;
- Williams, AnnaLynn M.;
- Baran, Andrea;
- Reagan, Patrick M.;
- Casulo, Carla;
- Zent, Clive S.;
- Evans, Andrew;
- Friedberg, Jonathan W.;
- Barr, Paul M.
Publication type:
Article
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).
Published in:
Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1636, doi. 10.1080/10428194.2020.1737690
By:
- Meacham, Philip J.;
- Williams, AnnaLynn M.;
- Strawderman, Myla;
- Baran, Andrea M.;
- Archibald, William J.;
- Wallace, Danielle S.;
- Tschernia, Nicholas P.;
- Burack, Walter Richard;
- Barr, Paul M.;
- Zent, Clive S.
Publication type:
Article
Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment.
Published in:
Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1627, doi. 10.1080/10428194.2020.1728748
By:
- Williams, AnnaLynn M.;
- van Wijngaarden, Edwin;
- Seplaki, Christopher L.;
- Heckler, Charles E.;
- Weber, Miriam T.;
- Barr, Paul M.;
- Zent, Clive S.;
- Janelsins, Michelle C.
Publication type:
Article
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation.
Published in:
2019
By:
- Loh, Kah Poh;
- Baran, Andrea;
- Lee, Christina Y.;
- Alshaibani, Alfadel;
- Rutherford, Sarah C.;
- Hu, John;
- Casulo, Carla;
- Barr, Paul M.;
- Friedberg, Jonathan W.;
- Reagan, Patrick M.
Publication type:
Letter
Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies.
Published in:
Leukemia & Lymphoma, 2018, v. 59, n. 3, p. 625, doi. 10.1080/10428194.2017.1347931
By:
- Williams, AnnaLynn M.;
- Baran, Andrea M.;
- Meacham, Philip J.;
- Feldman, Megan M.;
- Valencia, Hugo E.;
- Newsom-Stewart, Catherine;
- Gupta, Nealansh;
- Janelsins, Michelle C.;
- Barr, Paul M.;
- Zent, Clive S.
Publication type:
Article
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas.
Published in:
Leukemia & Lymphoma, 2016, v. 57, n. 3, p. 635, doi. 10.3109/10428194.2015.1075019
By:
- Holkova, Beata;
- Kmieciak, Maciej;
- Bose, Prithviraj;
- Yazbeck, Victor Y.;
- Barr, Paul M.;
- Tombes, Mary Beth;
- Shrader, Ellen;
- Weir-Wiggins, Caryn;
- Rollins, April D.;
- Cebula, Erin M.;
- Pierce, Emily;
- Herr, Megan;
- Sankala, Heidi;
- Hogan, Kevin T.;
- Wan, Wen;
- Feng, Changyong;
- Peterson, Derick R.;
- Fisher, Richard I.;
- Grant, Steven;
- Friedberg, Jonathan W.
Publication type:
Article
Infection in chronic lymphocytic leukemia: parsimony has its limits.
Published in:
Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2683, doi. 10.3109/10428194.2014.917642
By:
- Barr, Paul M.;
- Zent, Clive S.
Publication type:
Article